Who can use Hemlibra(Emicizumab)?

HEMLIBRA is indicated for routine prophylaxis to reduce bleeding frequency in hemophilia A patients of all ages.

Approved Use

HEMLIBRA is approved for routine prophylaxis in adults and pediatric patients (including newborns) with hemophilia A, whether they have developed factor VIII inhibitors or not. It helps prevent or reduce the frequency of bleeding episodes.